rosiglitazone has been researched along with gdc 0449 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colburn, D; Colevas, AD; Graham, RA; LoRusso, PM; Low, JA; Malhi, V; Mita, M; Piha-Paul, SA; Yin, M | 1 |
Kumar, V; Mahato, RI; Mundra, V | 1 |
1 trial(s) available for rosiglitazone and gdc 0449
Article | Year |
---|---|
Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential.
Topics: Aged; Anilides; Antineoplastic Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Cohort Studies; Contraceptives, Oral, Combined; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP3A; Drug Interactions; Ethinyl Estradiol; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Norethindrone; Pyridines; Rosiglitazone; Thiazolidinediones | 2013 |
1 other study(ies) available for rosiglitazone and gdc 0449
Article | Year |
---|---|
Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis.
Topics: Anilides; Animals; Base Sequence; Cytokines; DNA Primers; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Hedgehog Proteins; Inflammation Mediators; Liver Cirrhosis; Male; Nanomedicine; PPAR gamma; Proton Magnetic Resonance Spectroscopy; Pyridines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2014 |